Literature DB >> 12438587

Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages.

Secondo Sonza1, Helen P Mutimer, Kate O'Brien, Philip Ellery, Jane L Howard, Jonathan H Axelrod, Nicholas J Deacon, Suzanne M Crowe, Damian F J Purcell.   

Abstract

The transcription and splicing of human immunodeficiency virus type 1 (HIV-1) mRNA in primary blood monocyte-derived macrophages (MDM) and CD4(+) peripheral blood lymphocytes (PBL) were compared to determine whether any differences might account for the slower noncytopathic infection of cells of the macrophage lineage. The expression of regulatory mRNAs during acute infection of MDM was delayed by about 12 h compared to that of PBL. In each cell type, an increase in spliced viral mRNAs slightly preceded virus production from the culture. Following the peak of productive infection, there was a proportional decrease in the expression of all regulatory mRNAs detected in PBL. In MDM, a dramatic additional decrease specifically in the tat mRNA species heralded a reduction in virus production. This decline in tat mRNA was reflected by a concomitant decrease in Tat activity in the cells and occurred with the same kinetics irrespective of the age of the cells when infected. Addition of exogenous Tat protein elicited a burst of virus production from persistently infected MDM, suggesting that the decrease in virus production from the cultures is a consequence of the reduction in tat mRNA levels. Our results show that modulation of HIV-1 mRNAs in macrophages during long-term infection, which is dependent on the period of infection rather than cell differentiation or maturation, results in a selective reduction of Tat protein levels at the commencement of a persistent, less productive phase of infection. Determination of the mechanism of this mRNA modulation may lead to novel targets for control of replication in these important viral reservoirs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438587      PMCID: PMC136686          DOI: 10.1128/jvi.76.24.12611-12621.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

Review 1.  Reservoirs for HIV infection and their persistence in the face of undetectable viral load.

Authors:  S Sonza; S M Crowe
Journal:  AIDS Patient Care STDS       Date:  2001-10       Impact factor: 5.078

2.  Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.

Authors:  Tuofu Zhu; David Muthui; Sarah Holte; David Nickle; Feng Feng; Scott Brodie; Yon Hwangbo; James I Mullins; Lawrence Corey
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Rates of shutdown of HIV-1 into latency: roles of the LTR and tat/rev/vpu gene region.

Authors:  S K Song; H Li; M W Cloyd
Journal:  Virology       Date:  1996-11-15       Impact factor: 3.616

4.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.

Authors:  M A Muesing; D H Smith; C D Cabradilla; C V Benton; L A Lasky; D J Capon
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

5.  In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).

Authors:  J K Nicholson; G D Cross; C S Callaway; J S McDougal
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

6.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

7.  Human T lymphotropic virus type III infection of human alveolar macrophages.

Authors:  S Z Salahuddin; R M Rose; J E Groopman; P D Markham; R C Gallo
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

8.  mRNA decay during herpesvirus infections: interaction between a putative viral nuclease and a cellular translation factor.

Authors:  P Feng; D N Everly; G S Read
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.

Authors:  J Zhu; A Mayeda; A R Krainer
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

10.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

View more
  22 in total

1.  Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity.

Authors:  Joseph A Jablonski; Massimo Caputi
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

2.  HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing.

Authors:  Steven A Yukl; Philipp Kaiser; Peggy Kim; Sushama Telwatte; Sunil K Joshi; Mai Vu; Harry Lampiris; Joseph K Wong
Journal:  Sci Transl Med       Date:  2018-02-28       Impact factor: 17.956

3.  Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients.

Authors:  Rui S Soares; Rita Tendeiro; Russell B Foxall; António P Baptista; Rita Cavaleiro; Perpétua Gomes; Ricardo Camacho; Emília Valadas; Manuela Doroana; Margarida Lucas; Francisco Antunes; Rui M M Victorino; Ana E Sousa
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

4.  Assays for precise quantification of total (including short) and elongated HIV-1 transcripts.

Authors:  Philipp Kaiser; Sunil K Joshi; Peggy Kim; Peilin Li; Hongbing Liu; Andrew P Rice; Joseph K Wong; Steven A Yukl
Journal:  J Virol Methods       Date:  2016-12-27       Impact factor: 2.014

5.  Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.

Authors:  Rajnish S Dave; Roger J Pomerantz
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.

Authors:  Reem Berro; Kylene Kehn; Cynthia de la Fuente; Anne Pumfery; Richard Adair; John Wade; Anamaris M Colberg-Poley; John Hiscott; Fatah Kashanchi
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity.

Authors:  Steven Yukl; Satish Pillai; Peilin Li; Karen Chang; William Pasutti; Chris Ahlgren; Diane Havlir; Matthew Strain; Huldrych Günthard; Douglas Richman; Andrew P Rice; Eric Daar; Susan Little; Joseph K Wong
Journal:  Virology       Date:  2009-03-05       Impact factor: 3.616

8.  Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA.

Authors:  Alexander O Pasternak; Karen W Adema; Margreet Bakker; Suzanne Jurriaans; Ben Berkhout; Marion Cornelissen; Vladimir V Lukashov
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

9.  HIV-1 infection of T cells and macrophages are differentially modulated by virion-associated Hck: a Nef-dependent phenomenon.

Authors:  Alyssa Cornall; Johnson Mak; Alison Greenway; Gilda Tachedjian
Journal:  Viruses       Date:  2013-09-18       Impact factor: 5.048

10.  Development of a Novel In Vitro Primary Human Monocyte-Derived Macrophage Model To Study Reactivation of HIV-1 Transcription.

Authors:  Anna C Hearps; Anthony Jaworowski; Michelle E Wong; Chad J Johnson
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.